Select region
Menu
  • Products and Solutionsmore
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Servicesmore
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insightsmore
    • Academy
    • Articles
    • Events
    • Getinge Experience Center
    • Idea and invention submission

    • Insights main page →
  • Companymore
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • Grants and Charitable Donations
    • History

    • Company main page →
    • News
    • Legal Information
    • Product Catalog
    • COVID-19 Resource Center
    • Investors
    • Careers
  • Contact
  • Australia / New Zealand (English)
    • Global
      • International (English)
    • EMEA
      • Sverige (Svenska)
      • Deutschland (Deutsch)
      • France (Français)
      • United Kingdom / Ireland (English)
      • Italia (Italiano)
      • Türkiye (Türkçe)
      • Polska (polski)
      • Россия (русский)
      • Spain (Español)
      • Denmark (Dansk)
      • Norge (Norsk)
      • Suomi (Suomalainen)
      • Benelux (Nederlands)
    • Americas
      • United States (English)
      • Brazil (Português)
      • Canada (English)
      • Canada (Français)
      • Latin America (Español)
    • Asia
      • 日本 (日本語)
      • 中国 (中文)
      • 한국어(대한민국)
      • South East Asia (English)
      • India (English)
    • Oceania
      • Australia / New Zealand (English)
  • Products and Solutions
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Services
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insights
    • Academy
    • Articles
    • Events
    • Getinge Experience Center
    • Idea and invention submission

    • Insights main page →
  • Company
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • Grants and Charitable Donations
    • History

    • Company main page →
  • Contact
  • Start
  • Insights
  • Articles
  • Operating Room
  • Low-flow anesthesia
  • Why low-flow anesthesia?
  • Low-flow anesthesia offers pulmonary, economic and environmental benefits
  • Should we change to low- or minimal-flow anesthesia?
  • Theory and practice of minimal fresh gas flow anesthesia
  • What are potential risks of low-flow anesthesia?

Low-flow anesthesia

Topic
Operating Room
Patient under anesthesia
Topic
Operating Room

Why low-flow anesthesia?

Already in 1924 RM Waters published an article in Anesthesia and Analgesia where he presents improved economy, convenience and welfare of the patients as the benefits of using a re-breathing system during anesthesia [1]. This is still true today but we can also add welfare of the planet as another major benefit.

Low-flow anesthesia offers pulmonary, economic and environmental benefits

In low-flow anesthesia, a rebreathing system uses a fresh gas flow (FGF) that is less than the alveolar ventilation of the patient. This technique uses less anesthetic agents than conventional systems, emits less gas into the atmosphere, and improves the flow dynamics of the inhaled air. Low flow is generally characterized by a fresh gas flow of less than 1.0 L/min. In minimal flow, the FGF is decreased to 0.5 L/min.

Should we change to low- or minimal-flow anesthesia?

Reducing the fresh gas flow has several benefits:

web-anesthesia-low-flow-icon-economy-120x120.jpg

Economy

Agent expenditure accounts for a large part of the total cost of ownership of anesthesia machines. Reducing the anesthetic agent consumption in your ORs will have a positive impact on your overall hospital expenditure.

web-anesthesia-low-flow-environmental-120x120.jpg

Environmental impact

With low-flow anesthesia, a lower amount of anesthetic agent is released into the environment, reducing the impact of fluorocarbons and nitrous oxide on the ozone layer, thus reducing the overall greenhouse gas emissions.

web-anesthesia-low-flow-patient-safety-120x120.jpg

Patient comfort and safety

Low FGF improves the flow dynamics of inhaled gases, increases mucociliary clearance, maintains body temperature and reduces water loss. 

web-anesthesia-low-flow-staff-safety-120x120.jpg

OR staff safety

With less unused surplus gas discharged into the atmosphere, the concentration of anesthesia gas in the OR is greatly reduced. This minimizes occupational risk for OR staff.

Theory and practice of minimal fresh gas flow anesthesia

The review by Brattwall et al. in the Canadian Journal of Anesthesia, outlines the benefits of minimal fresh gas flow anesthesia.  It provides practical guidance on safe implementation of low- and minimal-flow anesthesia in routine clinical practice. [2]

What are potential risks of low-flow anesthesia?

Hypoxic mixtures

The formation of hypoxic mixtures are one of the greatest risk of using low-flow anesthesia. Reducing fresh gas flow in a rebreathing circle system results in a difference between the delivered O2 concentration(FD) at the common gas outlet and the inspired O2 (FIO2). Consequently, FIO2 becomes lower than the fraction of delivered oxygen (FDO2). This may not always be sufficiently recognized, and if settings are not adjusted, hypoxic mixtures can develop. An active inspired hypoxic guard has been shown to prevent the formation of hypoxic mixtures.

Learn how to avoid hypoxic mixtures

Inadequate depth of anesthesia

During low-flow anesthesia there is a potential risk for inadequate anesthetic gas concentration. An automatic gas control (AGC) system removes the need for continuous manual adjustments of FGF, FIO2 and EtAA. Targeting FIO2 directly will help avoid hypoxia. Targeting EtAA at the desired speed will reduce the risk of under- or overdosing.

Learn more about our Automatic Gas Control (AGC)

Related Articles

View all

Easy onboarding of new CSSD staff

Ensure guidance of your unexperienced staff and adapt to different user competency levels while maintaining a high and consistent quality level of the sterile production.

Digital Health
Operating Room
Sterile Reprocessing

Help reduce surgical site infections

Bacterial infections acquired in the operating room are the most common form of healthcare-associated infection. Using digital door-signs to minimize in-and-out traffic during surgeries effectively reduces this infection risk.

Digital Health
Operating Room

Optimized OR utilization with AI

At Klinikum Stuttgart AI technology enables better prediction of surgery times, more accurate surgical planning and an increase in correctly planned surgeries.

Digital Health
Operating Room

All references

  1. 1. Waters R.M 1924 Clinical scope and utility of carbon dioxid filtration in inhalation anesthesia. Anesthesia and Analgesia Feb p 20-22, 26

  2. 2. Brattwall M, et al. Brief review: Theory and practice of minimal fresh gas flow anesthesia. Can J Anesth/J Can Anesth (2012) 59:785–797

You are now leaving Getinge.com. You might access content  not managed by Getinge team, in that case Getinge can not be hold responsible of the content. 

I understand!

Dear user, you have clicked a link and will now see International fallback content.
Getinge ANZ does not review or control this content. It is possible that some of the products on Getinge International are not approved in your country. For more specific Australian information please contact us 

OK!

Dear user, You now see International fallback content. Getinge ANZ does not review or control this content. It is possible that some of the products on Getinge international are not approved in your country. For more specific  information relevant for your region please contact us.

Our offer

  • Products and Solutions
  • Services

Support and tools

  • Insights
  • Events
  • Past Webinars
  • Security

Company

  • Investors
  • Careers
  • Corporate Governance
  • History
  • Legal Information
  • Website Privacy Policy
  • Website use disclaimer
  • Cookie Notice
  • Data Subject Request Form
Get in contact
Australia / New Zealand (English)
  • Global
    • International (English)
  • EMEA
    • Sverige (Svenska)
    • Deutschland (Deutsch)
    • France (Français)
    • United Kingdom / Ireland (English)
    • Italia (Italiano)
    • Türkiye (Türkçe)
    • Polska (polski)
    • Россия (русский)
    • Spain (Español)
    • Denmark (Dansk)
    • Norge (Norsk)
    • Suomi (Suomalainen)
    • Benelux (Nederlands)
  • Americas
    • United States (English)
    • Brazil (Português)
    • Canada (English)
    • Canada (Français)
    • Latin America (Español)
  • Asia
    • 日本 (日本語)
    • 中国 (中文)
    • 한국어(대한민국)
    • South East Asia (English)
    • India (English)
  • Oceania
    • Australia / New Zealand (English)
Australia / New Zealand (English)

© 2025 Getinge │ Getinge and 

Getinge_Logo_hz_RGB_neg.png

are trademarks or registered trademarks of Getinge AB, its subsidiaries or affiliates │All rights reserved.

March 2025

This information is aimed exclusively at healthcare professionals or other professional audiences and is for informational purposes only, is not exhaustive and therefore should not be relied upon as a replacement of the Instructions for Use, service manual or medical advice. Getinge shall bear no responsibility or liability for any action or omission of any party based upon this material, and reliance is solely at the user’s risk.
Any therapy, solution or product mentioned might not be available or allowed in your country. Information may not be copied or used, in whole or in part, without written permission by Getinge.

This information is intended for an international audience outside the US.

Views, opinions, and assertions expressed are strictly those of the interviewed and do not necessarily reflect or represent the views of Getinge.